ru24.pro
News in English
Декабрь
2024
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
19
20
21
22
23
24
25
26
27
28
29
30
31

Новости за 17.12.2024

Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

Jamanetwork.com 

This phase 2 randomized clinical trial evaluates the optimal dose, dosing interval, and safety of zerlasiran, a small-interfering RNA targeting hepatic synthesis of apolipoprotein(a), to treat patients with atherosclerotic cardiovascular disease and elevated lipoprotein(a) concentration.

Massage

Jamanetwork.com 

Passport stored in a basket, I press my face to a halo pillow so someone will touch and touch me. I wait within a synthetic cadence of ocean waves’ crescendos. The body is a lonely crossroads. At first you only hover, flutter. Then you lash and drub me like the sea. Your oiled hands stretch and strain. Your joints pass bone to bore into muscle. You keep me close to whimpers. For this I paid, but not so dearly. To see your eyes would be a violation, though I can’t say why. I feel your work is tougher than mine... Читать дальше...

Hypertension Risk and Kidney Function Following Kidney Donation—Reply

Jamanetwork.com 

In Reply We appreciate the comments provided by Drs Lin and Huang. In theory, randomized trials could generate unbiased estimates of donor risk; however, randomized trials of living kidney donation are not ethically feasible. The best possible approach is to conduct a multicenter prospective cohort study that enrolls donors and nondonors with similar indicators of baseline health and follows them with minimal loss to follow-up for outcomes. We conducted such a study to produce estimates of kidney... Читать дальше...

Hypertension Risk and Kidney Function Following Kidney Donation

Jamanetwork.com 

To the Editor A recent study reported no significant difference in the risk of hypertension and albuminuria among living kidney donors and nondonors over a median follow-up of 7.3 years. In their Editorial, Drs Lorenz and Winkelmayer outlined some limitations of this study, and we have some additional concerns about the results.

A Simple Question

Jamanetwork.com 

In this narrative medicine essay, an emeritus professor of otolaryngology resists offering an affirmative response to a deceptively simple question about a complex reality.

Patient Information: Accidental Poisoning

Jamanetwork.com 

This JAMA Patient Page describes common causes of accidental poisoning, risk reduction, and what to do in case of an accidental poisoning.

When Does CHD Start?

Jamanetwork.com 

Studies that link coronary heart disease (CHD) to the status of health during childhood concentrate on three main areas: (1) elevated levels of cholesterol and triglicerides, even in infancy, (2) genetic inclination to CHD in children of CHD victims, and (3) histological differences in the structure of the coronary vessel wall in children of families with higher or lower incidence of CHD.

How Should the FDA Regulate AI in Health Care?

Jamanetwork.com 

This Medical News article is an interview with FDA Commissioner Robert Califf, MD, about the agency’s regulatory powers over artificial intelligence tools for use in health care and biomedicine.

Meta-Analysis: AI-Assisted Colonoscopy Increases Detection of Polyps, Adenomas

Jamanetwork.com 

After the US Food and Drug Administration first authorized a medical device that harnessed artificial intelligence (AI) to assist in colonoscopies in 2021, the use of this computer-aided detection technology has grown. Now, new research shows that AI-assisted colonoscopies result in the detection of more polyps and adenomas than traditional methods with only a minimal increase in procedure time.

Empagliflozin’s Cardiorenal Benefits Appear to Persist

Jamanetwork.com 

A follow-up of a randomized clinical trial found that positive effects of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, were seen up to a year after patients with chronic kidney disease stopped treatment.

Mpox Vaccine Appears Safe for Use in Adolescents

Jamanetwork.com 

The modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is approved in several countries for use in the prevention of mpox and smallpox in adults. New research suggests it’s also safe and produces an immune response in adolescents, a population affected by the current clade I mpox outbreak.

Study Highlights Need for Expanded Access to Birth Control Beyond In-Person Visits

Jamanetwork.com 

Although about three-fourths of people using short-acting, reversible contraception reported receiving it in person in a US survey, only about a third considered that their most preferred way to obtain birth control. The findings from a nationally representative survey, published in JAMA Network Open, highlight a need for expanded access to alternative sources, the authors noted.

Gambling Disorders Affect 80 Million Globally, Fueling Public Health Concerns

Jamanetwork.com 

As the gambling industry continues to transform through digitalization and the rapid rise of online betting options, a new systematic review and meta-analysis in The Lancet Public Health suggests that an estimated 80 million adults globally experience gambling disorder or problematic gambling.

Evan Cowley (G) from Asiago

Elite Prospects 

Date: 12/17/2024
Player: Evan Cowley (G)
From: Asiago
Information: Personal reasons
Source: You need a free account to view Transfer URL Sign In/Up